Search results
PET Technology Now Available At Rood & Riddle Equine Hospital In Saratoga Springs
Paulick Report· 3 days agoA PET scanner can produce three-dimensional, cross-sectional images. The New York Racing Association...
Mount Sinai researchers discover potential new the | Newswise
Newswise· 22 hours agoBottom Line: Researchers at the Abimael Laboratory of Neurometabolism and the Neurometabolomics & Neuroinformatics core at Mount Sinai have discovered a potential new therapy, improved an existing ...
Here's Why You Should Add Lantheus (LNTH) to Your Portfolio Now
Zacks via Yahoo Finance· 6 days agoStrength in Radiopharmaceuticals: Lantheus has established itself as a leader in the...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 3 days agoTelix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has completed the submission of a Biologics License Application (BLA) to the United States (U.S.) Food and ...
Ask the Doctors: PET scans create images of body at cellular level
The Daily Reflector· 20 hours agoQ My wife is 59 years old. She had COVID-19 but recovered. A recent chest X-ray shows a white patch...
How Can Biomarkers Help Diagnose Alzheimer's?
Healthline· 20 hours agoAlzheimer’s disease is a neurodegenerative condition that can cause difficulties with thinking and memory and physical decline. Biomarkers can help...
Tennessee General Assembly Continues Chipping Away at Tennessee’s CON Program | JD Supra
JD Supra· 6 days agoOn April 23, the 113th Tennessee General Assembly passed HB2269/SB2009, Public Chapter No. 985 (New CON Law), which significantly overhauls...
Small Business - Picayune Item | Picayune Item
The Picayune Item· 7 days agoPARIS, May 30, 2024 (GLOBE NEWSWIRE) -- Curium, a world leader in nuclear medicine, today announced that earlier this month patients in France received the first doses of PYLCLARI® (INN: Piflufolastat (18F) also known as (18F)-DCFPyL) indicated
Navidea Biopharmaceuticals (NYSE:NAVB) Earns Sell Rating from Analysts at StockNews.com
ETF DAILY NEWS· 6 days agoAnalysts at StockNews.com assumed coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Get Free Report) in a research note issued on Friday. The firm set a “sell” rating on the stock ...
